See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600620_2021_Aurinia_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001600620, Aurinia Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 419,427,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,332,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,786,000 |
| 3 | remainder_Assets | 30,116,000 |
| 4 | LiabilitiesCurrent | 31,997,000 |
| 5 | LiabilitiesNoncurrent | 9,208,000 |
| 6 | remainder_Liabilities | 14,706,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 95,983,000 |
| 9 | ResearchAndDevelopmentExpense | 50,327,000 |
| 10 | remainder_Expenses | 8,004,000 |
| 11 | remainder_Revenues | 50,118,000 |
| 12 | remainder_NetIncome | 1,516,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 463,661,000 |
| 1 | Liabilities | 55,911,000 |
| 2 | Expenses | 154,314,000 |
| 3 | Revenues | 50,118,000 |
| 4 | StockholdersEquity | 407,750,000 |
| 5 | NetIncome | -102,680,000 |
| 6 | ComprehensiveNetIncome | -102,680,000 |
| 7 | BaseVar | 362,760,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.03 |
| 9 | EconomicCapitalRatio | 3.70 |
Edgar->Model Mapping
Feature Distribution
